Section Arrow
ANRO.NYSE
- Alto Neuroscience
Quotes are at least 15-min delayed:2024/05/13 20:32 EDT
Last
 14.09
+0.6 (+4.45%)
Day High 
14.4 
Prev. Close
13.49 
1-M High
16.535 
Volume 
115.33K 
Bid
13.5
Ask
16
Day Low
13.54 
Open
13.68 
1-M Low
12.7798 
Market Cap 
362.66M 
Currency USD 
P/E -- 
%Yield
10-SMA 14.71 
20-SMA 14.24 
50-SMA 14.65 
52-W High 24 
52-W Low 12.7798 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.42/--
Enterprise Value
372.53M
Balance Sheet
Book Value Per Share
-2.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NVAXNovavax13.11+4.23+47.64%-- 
DNAGinkgo Bioworks Holdings0.8407+0.0798+10.49%-- 
ACIUAC Immune SA3.3+0.99+42.86%-- 
JAGXJaguar Health0.290795-0.001305-0.45%-- 
TVGNTevogen Bio Holdings1+0.0155+1.57%-- 
Quotes are at least 15-min delayed:2024/05/13 20:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.